$176.0 Million
Biomea Fusion
Initial Public Offering
Active Bookrunner
$284.7 Million
Cytek Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$97.8 Million
Nyxoah S.A.
Initial Public Offering
Left Bookrunner
$398.9 Million
InnovAge Holding Corp.
Initial Public Offering
Passive Bookrunner
$276.0 Million
Design Therapeutics
Initial Public Offering
Active Bookrunner
$93.7 Million
Reneo Pharmaceuticals
Initial Public Offering
Active Bookrunner
$253.9 Million
Talis Biomedical
Initial Public Offering
Active Bookrunner
$152.5 Million
Sensei Biotherapeutics, Inc.
Initial Public Offering
Active Bookrunner
$151.3 Million
Akoya Biosciences, Inc.
Initial Public Offering
Active Bookrunner
$219.9 Million
Connect Biopharma
Initial Public Offering
Active Bookrunner
Subscribe to Financing

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.